• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RelA核因子-κB亚基的不同结构域对于负向串扰以及与糖皮质激素受体的直接相互作用是必需的。

Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor.

作者信息

Wissink S, van Heerde E C, Schmitz M L, Kalkhoven E, van der Burg B, Baeuerle P A, van der Saag P T

机构信息

Hubrecht Laboratory, Netherlands Institute for Developmental Biology, Utrecht, The Netherlands.

出版信息

J Biol Chem. 1997 Aug 29;272(35):22278-84. doi: 10.1074/jbc.272.35.22278.

DOI:10.1074/jbc.272.35.22278
PMID:9268377
Abstract

The RelA subunit of NF-kappaB and the glucocorticoid receptor mutually repress each others transcriptional activity, thus providing a mechanism for immunosuppression. Deletion analysis of the glucocorticoid receptor has shown that the DNA binding domain and the ligand binding domain are essential components for repression. Here, we show by deletions and point mutations that both the Rel homology domain and the transactivation domains of RelA are required for repression of the transcriptional activity of the glucocorticoid receptor in intact cells. However, only the Rel homology domain of RelA was found to associate with the glucocorticoid receptor in vitro. RelA mutants, not able to repress glucocorticoid receptor activity, but still able to dimerize, behaved as transdominant inhibitors of the repressive activity of wild type RelA. Furthermore, we show that the 13 S E1A protein is able to interfere with the transrepressive activity of RelA. We propose that negative cross-talk between the glucocorticoid receptor and RelA is due to direct interaction via the Rel homology domain of RelA and the DNA binding domain of the glucocorticoid receptor in combination with interference by the transactivation domains of RelA with the transcriptional activity of the glucocorticoid receptor.

摘要

核因子-κB的RelA亚基与糖皮质激素受体相互抑制彼此的转录活性,从而提供了一种免疫抑制机制。对糖皮质激素受体的缺失分析表明,DNA结合结构域和配体结合结构域是抑制作用的关键组成部分。在此,我们通过缺失和点突变表明,RelA的Rel同源结构域和反式激活结构域对于完整细胞中糖皮质激素受体转录活性的抑制都是必需的。然而,在体外仅发现RelA的Rel同源结构域与糖皮质激素受体相关联。不能抑制糖皮质激素受体活性但仍能二聚化的RelA突变体,表现为野生型RelA抑制活性的反式显性抑制剂。此外,我们表明13S E1A蛋白能够干扰RelA的反式抑制活性。我们提出,糖皮质激素受体与RelA之间的负性相互作用是由于RelA的Rel同源结构域与糖皮质激素受体的DNA结合结构域直接相互作用,同时RelA的反式激活结构域干扰了糖皮质激素受体的转录活性。

相似文献

1
Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor.RelA核因子-κB亚基的不同结构域对于负向串扰以及与糖皮质激素受体的直接相互作用是必需的。
J Biol Chem. 1997 Aug 29;272(35):22278-84. doi: 10.1074/jbc.272.35.22278.
2
Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.RelA与糖皮质激素受体之间的负性相互作用:糖皮质激素抗炎作用的一种可能机制。
Mol Endocrinol. 1995 Apr;9(4):401-12. doi: 10.1210/mend.9.4.7659084.
3
CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism.CBP(CREB结合蛋白)整合了NF-κB(核因子κB)与糖皮质激素受体的物理相互作用及拮抗作用。
Mol Endocrinol. 2000 Aug;14(8):1222-34. doi: 10.1210/mend.14.8.0506.
4
A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation.糖皮质激素受体C末端锌指的新功能。RelA反式激活的抑制作用。
J Biol Chem. 1997 Aug 22;272(34):21467-72. doi: 10.1074/jbc.272.34.21467.
5
p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.p300/CREB结合蛋白通过与Stat5的反式激活结构域直接相互作用增强催乳素介导的转录诱导,但不参与Stat5介导的糖皮质激素反应抑制。
Mol Endocrinol. 1998 Oct;12(10):1582-93. doi: 10.1210/mend.12.10.0180.
6
Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism.核因子-κB与类固醇激素受体之间的相互作用:相互拮抗的机制
Mol Endocrinol. 1998 Jan;12(1):45-56. doi: 10.1210/mend.12.1.0044.
7
Mutual transcriptional interference between RelA and androgen receptor.RelA与雄激素受体之间的相互转录干扰。
J Biol Chem. 1996 Sep 27;271(39):24151-6. doi: 10.1074/jbc.271.39.24151.
8
Basal transcription factors TBP and TFIIB and the viral coactivator E1A 13S bind with distinct affinities and kinetics to the transactivation domain of NF-kappaB p65.基础转录因子TBP和TFIIB以及病毒共激活因子E1A 13S以不同的亲和力和动力学与核因子-κB p65的反式激活结构域结合。
Nucleic Acids Res. 1997 Mar 1;25(5):1050-5. doi: 10.1093/nar/25.5.1050.
9
The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.核因子-κB的p65(RelA)亚基与组蛋白去乙酰化酶(HDAC)共抑制因子HDAC1和HDAC2相互作用,以负向调节基因表达。
Mol Cell Biol. 2001 Oct;21(20):7065-77. doi: 10.1128/MCB.21.20.7065-7077.2001.
10
Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1.通过 CREB 结合蛋白和类固醇受体辅激活因子-1实现糖皮质激素受体与核因子-κB信号通路的核整合。
J Biol Chem. 1998 Nov 6;273(45):29291-4. doi: 10.1074/jbc.273.45.29291.

引用本文的文献

1
A new p65 isoform that bind the glucocorticoid hormone and is expressed in inflammation liver diseases and COVID-19.一种新的 p65 同种型,可结合糖皮质激素,并在炎症性肝病和 COVID-19 中表达。
Sci Rep. 2021 Nov 25;11(1):22913. doi: 10.1038/s41598-021-02119-z.
2
Cell-Matrix Interactions in the Eye: From Cornea to Choroid.眼睛中的细胞-基质相互作用:从角膜到脉络膜。
Cells. 2021 Mar 20;10(3):687. doi: 10.3390/cells10030687.
3
Mechanisms Underlying the Functional Cooperation Between PPARα and GRα to Attenuate Inflammatory Responses.PPARα 与 GRα 功能合作的作用机制及其对炎症反应的抑制作用。
Front Immunol. 2019 Aug 9;10:1769. doi: 10.3389/fimmu.2019.01769. eCollection 2019.
4
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression.NF-κB p65 二聚化和 DNA 结合对于炎症基因表达很重要。
FASEB J. 2019 Mar;33(3):4188-4202. doi: 10.1096/fj.201801638R. Epub 2018 Dec 7.
5
VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects.VBP15,一种新型的抗炎和稳定细胞膜药物,可改善肌肉萎缩症而无副作用。
EMBO Mol Med. 2013 Oct;5(10):1569-85. doi: 10.1002/emmm.201302621. Epub 2013 Sep 9.
6
Nuclear receptors in inflammation control: repression by GR and beyond.核受体在炎症控制中的作用:GR 的抑制作用及其他。
Mol Cell Endocrinol. 2013 Nov 5;380(1-2):55-64. doi: 10.1016/j.mce.2013.04.006. Epub 2013 Apr 26.
7
NF-κB repression by PIAS3 mediated RelA SUMOylation.PIAS3 通过 RelA SUMOylation 抑制 NF-κB。
PLoS One. 2012;7(5):e37636. doi: 10.1371/journal.pone.0037636. Epub 2012 May 23.
8
Elucidating the identity of resistance mechanisms to prednisolone exposure in acute lymphoblastic leukemia cells through transcriptomic analysis: A computational approach.通过转录组分析阐明急性淋巴细胞白血病细胞中对泼尼松龙暴露的耐药机制的身份:一种计算方法。
J Clin Bioinforma. 2011 Dec 20;1:36. doi: 10.1186/2043-9113-1-36.
9
SHP limits TLR signaling, an inducible transcriptional corepressor.SHP限制TLR信号传导,一种可诱导的转录共抑制因子。
Cell Mol Immunol. 2011 Nov;8(6):445-6. doi: 10.1038/cmi.2011.31. Epub 2011 Aug 22.
10
Nuclear factor-κB: a key regulator in health and disease of lungs.核因子-κB:肺部健康和疾病的关键调节因子。
Arch Immunol Ther Exp (Warsz). 2011 Oct;59(5):335-51. doi: 10.1007/s00005-011-0136-z. Epub 2011 Jul 26.